New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 15, 2014
07:03 EDTBRKRBruker receives two orders for FT-NIR spectrometers in China
Bruker Corporation announced that it recently has received two significant orders of TANGO and MATRIX-I FT-NIR spectrometers from leading animal nutrition companies in the People’s Republic of China. Da Bei Nong Science and Technology Group has ordered 25 TANGO spectrometers for the analysis of raw materials and finished products in their production bases all over China. New Hope Liuhe Group placed a single order for 23 MATRIX-I FT-NIR spectrometers to complement over 60 existing Bruker Optics spectrometers, which are already operating successfully in a large analysis network in Liuhe’s production facilities.
News For BRKR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 6, 2015
09:59 EDTBRKRBruker's Jordan Valley acquisition to add roughly 1c-2c to FY16 EPS
Subscribe for More Information
09:58 EDTBRKRBruker to acquire Jordan Valley Semiconductors, terms not disclosed
Bruker Corporation announced the signing of an agreement to acquire the shares of Jordan Valley Semiconductors. The acquisition uniquely positions Bruker to offer unmatched solutions for advanced problems in nanotechnology research and semiconductor metrology. With trends toward increased connectivity and access to even larger amounts of data, new nanometrology needs are driving growth opportunities at advanced semiconductor nodes with even smaller features and three dimensional structures. Financial details of the transaction were not disclosed. The transaction is expected to close in the fourth quarter of 2015.
07:33 EDTBRKRBruker BioSpin pricing improving, says Wells Fargo
After speaking with the directors of four large Nuclear Magnetic Resonance labs, which are either current or prospective Bruker customers, Wells Fargo thinks that the pricing of the company's BioSpin division, which accounts for 34% of its revenue, is rising. The firm recommends buying the stock following its recent decline. It says that the company's NMR customers appear to be satisfied, and it keeps an Outperform rating on the shares.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use